X-51744049-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_018094.5(GSPT2):c.423G>A(p.Glu141=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00194 in 1,208,603 control chromosomes in the GnomAD database, including 33 homozygotes. There are 658 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.010 ( 13 hom., 331 hem., cov: 23)
Exomes 𝑓: 0.0011 ( 20 hom. 327 hem. )
Consequence
GSPT2
NM_018094.5 synonymous
NM_018094.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.40
Genes affected
GSPT2 (HGNC:4622): (G1 to S phase transition 2) This gene encodes a GTPase that belongs to the GTP-binding elongation factor family. The encoded protein is a polypeptide release factor that complexes with eukaryotic peptide chain release factor 1 to mediate translation termination. This protein may also be involved in mRNA stability.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant X-51744049-G-A is Benign according to our data. Variant chrX-51744049-G-A is described in ClinVar as [Benign]. Clinvar id is 769180.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.4 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0102 (1139/111845) while in subpopulation AFR AF= 0.0355 (1091/30731). AF 95% confidence interval is 0.0338. There are 13 homozygotes in gnomad4. There are 331 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GSPT2 | NM_018094.5 | c.423G>A | p.Glu141= | synonymous_variant | 1/1 | ENST00000340438.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GSPT2 | ENST00000340438.6 | c.423G>A | p.Glu141= | synonymous_variant | 1/1 | NM_018094.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0102 AC: 1139AN: 111792Hom.: 13 Cov.: 23 AF XY: 0.00974 AC XY: 331AN XY: 33972
GnomAD3 genomes
AF:
AC:
1139
AN:
111792
Hom.:
Cov.:
23
AF XY:
AC XY:
331
AN XY:
33972
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00280 AC: 500AN: 178623Hom.: 10 AF XY: 0.00181 AC XY: 115AN XY: 63705
GnomAD3 exomes
AF:
AC:
500
AN:
178623
Hom.:
AF XY:
AC XY:
115
AN XY:
63705
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1210AN: 1096758Hom.: 20 Cov.: 31 AF XY: 0.000903 AC XY: 327AN XY: 362180
GnomAD4 exome
AF:
AC:
1210
AN:
1096758
Hom.:
Cov.:
31
AF XY:
AC XY:
327
AN XY:
362180
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0102 AC: 1139AN: 111845Hom.: 13 Cov.: 23 AF XY: 0.00973 AC XY: 331AN XY: 34035
GnomAD4 genome
AF:
AC:
1139
AN:
111845
Hom.:
Cov.:
23
AF XY:
AC XY:
331
AN XY:
34035
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at